Instituto de Infectologia Emílio Ribas, São Paulo SP, Brazil.
Universidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, São Paulo SP, Brazil.
Arq Neuropsiquiatr. 2023 Jan;81(1):33-39. doi: 10.1055/s-0042-1759758. Epub 2023 Mar 14.
Concomitant neurological diseases in people living with HIV/AIDS (PLWHA) is a challenging subject that has been insufficiently evaluated by prospective clinical studies. The goal of the present study was to identify the clinical characteristics and outcomes of PLWHA with cerebral toxoplasmosis and neurological co-infections.
We conducted a prospective observational cohort study at a tertiary teaching center in São Paulo, Brazil, from January to July 2017. Hospitalized PLWHA aged ≥ 18 years with cerebral toxoplasmosis were consecutively enrolled. A standardized neurological examination was performed at admission and weekly until discharge or death. Diagnosis and treatment followed institutional routines; neuroradiology, molecular diagnosis, neurosurgery, and the intensive care unit (ICU) were available. The main outcomes were neurological coinfections and in-hospital death.
We included 44 (4.3%) cases among 1,032 hospitalized patients. The median age was 44 (interquartile range [IQR]: 35-50) years, and 50% (n = 22) of the patients were male. The median CD4+ T lymphocyte count was of 50 (IQR: 15-94) cells/mm. Multiple lesions on computed tomography were present in 59% of the cases. Neurological coinfections were diagnosed in 20% (n = 9) of the cases, and cytomegalovirus was the most common etiology (encephalitis: n = 3; polyradiculopathy: n = 2). Longer hospital stays (30 versus 62 days; = 0.021) and a higher rate of ICU admissions (14% versus 44%; = 0.045) were observed among PLWHA with neurological coinfections in comparison to those without them. The rate of in-hospital mortality was of 13.6% (n = 6) (coinfection group: 33%; no coinfection group: 8.6%; = 0.054).
Neurological c-infections were common among PLWHA with cerebral toxoplasmosis, and cytomegalovirus was the main copathogen. The group of PLWHA with neurological co-infections underwent longer hospital stays and more frequent intensive care unit admissions. Additionally, this group of patients tended to have higher in-hospital mortality rate.
在感染人类免疫缺陷病毒/艾滋病(PLWHA)的人群中同时存在神经疾病是一个具有挑战性的问题,这一问题在前瞻性临床研究中评估不足。本研究的目的是确定患有脑弓形虫病和神经合并感染的 PLWHA 的临床特征和结局。
我们在巴西圣保罗的一家三级教学中心进行了一项前瞻性观察队列研究,时间为 2017 年 1 月至 7 月。连续纳入年龄≥18 岁、患有脑弓形虫病的住院 PLWHA。入院时和每周进行一次标准化的神经系统检查,直至出院或死亡。诊断和治疗遵循机构常规;神经放射学、分子诊断、神经外科和重症监护病房(ICU)可提供。主要结局是神经合并感染和院内死亡。
在 1032 名住院患者中,我们纳入了 44 例(4.3%)。中位年龄为 44(四分位距 [IQR]:35-50)岁,50%(n=22)的患者为男性。中位 CD4+T 淋巴细胞计数为 50(IQR:15-94)个/毫米。59%的病例存在多发性脑损伤。诊断出神经合并感染的病例占 20%(n=9),最常见的病因是巨细胞病毒(脑炎:n=3;多神经根病:n=2)。与无神经合并感染的 PLWHA 相比,有神经合并感染的 PLWHA 住院时间更长(30 天与 62 天;=0.021),入住 ICU 的比例更高(14%与 44%;=0.045)。与无神经合并感染的患者相比,患有神经合并感染的患者的院内死亡率为 13.6%(n=6)(合并感染组:33%;无合并感染组:8.6%;=0.054)。
脑弓形虫病的 PLWHA 中常见神经合并感染,巨细胞病毒是主要的合并病原体。有神经合并感染的 PLWHA 住院时间更长,入住 ICU 的比例更高。此外,该组患者的院内死亡率较高。